Login
$GCTS
$1.15 -$0.02 (1.71%) After hours

Company Executives

Officer Age In this role Source
Edmond Cheng
Chief Financial Officer
65 Since 2024
2 years
John Schlaefer Also a director
President, CEO & Class III Dir
Title from the Form 4 dated Sep 10, 2026
62 Not stated
Jeongmin Kim
Vice President of Engineering and Chief Technology Officer
55 Not stated
Jeong-Min Kim
Chief Technology Officer
Title from the Form 4 dated Sep 10, 2026
Not stated Not stated
Alex Sum
Sr. Vice President of Sales and Marketing
78 Not stated

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
Dr. Kyeongho Lee
Director Age On board Independent Committees Other public boards 2025 pay Source
Dr. Kyeongho Lee
56 Not stated Independent
Compensation Committee · Chair Nominating and Corporate Governance Committee
Anapass, Inc. $165,000
John Schlaefer
62 Not stated Not independent None stated None stated Paid as CEO
Robert J. Barker
80 2024
2 years
Independent
Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated $180,000
Hyunsoo Shin
71 2024
2 years
Independent None stated None stated $162,500
Jeff Tuder
53 2024
2 years
Independent
Compensation Committee
Inseego Corp $162,500
Nelson C. Chan
65 2024
2 years
Independent
Nominating and Corporate Governance Committee
Synaptics Incorporated $162,500
Dr. Kukjin Chun
71 2024
2 years
Independent None stated None stated $162,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

7 disclosed in the proxy filed Aug 3, 2026
the Sponsor
sponsor of Concord III
$25,000
2021

Sponsor purchased Founder Shares for a capital contribution

With Concord III Open in proxy
the Sponsors
sponsors of Concord III
$6,900,000

Sponsors lent Concord III Sponsor Loans at no interest, added to the Trust Account

With Concord III Open in proxy
an affiliate of the Sponsor
affiliate of the Sponsor
$20,000 per month

Administrative Services Agreement fees for office space, administrative and support services

With Concord III Open in proxy
Anapass, Inc.
beneficial owner of approximately 9.8% of the issued and outstanding shares of GCT common stock; Dr. Lee serves as chairman of its board
Amount not stated
2016

Secured term note loan from Anapass to GCT Research bearing 5.5% annual interest

With GCT Research, Inc. Open in proxy
Amount not stated
2017

Unsecured term note loan from Dr. Lee to GCT Research bearing 8.5% annual interest

With GCT Research Open in proxy
Amount not stated
2024

Unsecured term loan from Dr. Lee to GCT Research bearing 12.0% annual interest

With GCT Research Open in proxy
Amount not stated
2025

Unsecured term loan from Dr. Lee to GCT Research bearing 12.0% annual interest

With GCT Research Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support